Signia Therapeutics will be present at the Bio Europe in Copenhagen
October 02, 2018
Signia Therapeutics is pleased to announce that it will participate at the Bio Europe partnering conference in Copenhagen on November ...
Read more
Signia Therapeutics will be present at BIO 2018 in Boston
May 10, 2018
Signia Therapeutics is pleased to announce that it will have several activities during the BIO 2018 that will be held in Boston ...
Read more
Signia Therapeutics will participate to the 21st Edition of the Venture5i
May 09, 2018
Signia Therapeutics is pleased to announce that it has been selected to present and participate at the 21st editio ...
Read more
EU H2020 Seal of Excellence for Signia Therapeutics
April 27, 2018
We are very proud to announce that Signia Therapeutics has been awarded the Seal of Excellence by the EU H2020 Framework Program ...
Read more
Signia Therapeutics will participate to major partnering events in February/March 2018
February 22, 2018
11th Annual European Life Science CEO Forum, in Zurich (26-27 February 2018) Read more
Signia Therapeutics annonce un accord majeur de Licence et le lancement d’un essai de phase 2
January 22, 2018
La start-up Signia Therapeutics vient de signer un accord majeur de licence avec l’Université Claude Bernard de Lyon (UCBL) et l’ ...
Read more
Signia Therapeutics announces achievement of corporate milestones
November 28, 2017
LYON, FRANCE (November 28, 2017) – Signia Therapeutics is an emerging company, spin-off company of VirPath laboratoy/Universit ...
Read more
Signia Therapeutics Laureate of i-Lab2017 award
July 06, 2017
We are very proud to announce that Signia Therapeutics is laureate of the i-Lab 2017 award from the French Ministry of Higher Ed ...
Read more